Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Lynx1 Capital Management LP (CIK 1910456) reported $632.7M across 23 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: STOK ($155.1M, 24.51%), GHRS ($151.3M, 23.92%), CGEM ($127.4M, 20.13%), AGIO ($88.3M, 13.96%), DNLI ($36.1M, 5.71%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | STOK | STOKE THERAPEUTICS INC | $155.1M | 24.51% | 4.8M | Trimmed |
| 2 | GHRS | GH RESEARCH PLC | $151.3M | 23.92% | 10.8M | Added |
| 3 | CGEM | CULLINAN THERAPEUTICS INC | $127.4M | 20.13% | 9.0M | Hold |
| 4 | AGIO | AGIOS PHARMACEUTICALS INC | $88.3M | 13.96% | 2.6M | Added |
| 5 | DNLI | DENALI THERAPEUTICS INC | $36.1M | 5.71% | 1.9M | Added |
| 6 | CCCC | C4 THERAPEUTICS INC | $18.4M | 2.91% | 7.0M | Trimmed |
| 7 | KRRO | KORRO BIO INC | $17.4M | 2.75% | 1.5M | Added |
| 8 | TCRX | TSCAN THERAPEUTICS INC | $8.1M | 1.28% | 8.0M | Hold |
| 9 | XNCR | XENCOR INC | $6.5M | 1.02% | 536,398 | Trimmed |
| 10 | DTIL | PRECISION BIOSCIENCES INC | $5.4M | 0.86% | 985,113 | Trimmed |
| 11 | PASG | PASSAGE BIO INC | $4.9M | 0.77% | 623,704 | Hold |
| 12 | NEUP | NEUPHORIA THERAPEUTICS INC | $3.6M | 0.56% | 875,328 | Added |
| 13 | TRDA | ENTRADA THERAPEUTICS INC | $2.7M | 0.42% | 211,689 | Added |
| 14 | CGON | CG ONCOLOGY INC | $2.1M | 0.34% | 31,591 | Hold |
| 15 | IMTX | IMMATICS N.V | $2.1M | 0.34% | 216,973 | Trimmed |
| 16 | DSGN | DESIGN THERAPEUTICS INC | $1.3M | 0.20% | 119,516 | Added |
| 17 | VYNE | VYNE THERAPEUTICS INC | $973,148 | 0.15% | 1.6M | New |
| 18 | HOWL | WEREWOLF THERAPEUTICS INC | $547,673 | 0.09% | 657,786 | Added |
| 19 | BOLT | BOLT BIOTHERAPEUTICS INC | $124,432 | 0.02% | 30,800 | New |
| 20 | IBIO | IBIO INC | $129,344 | 0.02% | 68,076 | New |
| 21 | PRQR | PROQR THRAPEUTICS N V | $110,947 | 0.02% | 68,486 | Hold |
| 22 | ABSI | ABSCI CORPORATION | $63,735 | 0.01% | 21,245 | New |
| 23 | APLT | APPLIED THERAPEUTICS INC | $0 | 0.00% | 0 | Exited |
| 24 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $0 | 0.00% | 0 | Exited |
| 25 | GBIO | GENERATION BIO CO | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2026-03-31